Cost-effectiveness of smoking cessation in patients with non-small cell lung cancer

被引：0
|
作者：
Kunde, Katharina
机构：
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2023年 / 28卷 / 04期
关键词：
D O I：
10.1055/a-2109-6934
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF TORACOTOMY VERSUS VIDEOTORACOSCOPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN STADIUM
    Guevara, G. A.
    Parody, E.
    Aguirre, A. F.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A821 - A821
  • [2] Cost-effectiveness of diagnostic interventions. Non-small cell lung cancer
    Langer, A.
    [J]. ONKOLOGE, 2010, 16 (10): : 992 - +
  • [3] Smoking cessation and survival in early stage non-small cell lung cancer patients
    Christiani, David C.
    Suk, Rebecca
    Liu, Geoffrey
    Park, Sohee
    Neuberg, Donna S.
    Wain, John C.
    Lynch, Thomas J.
    Zhou, Wei
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [4] Cost-effectiveness of additional serplulimab to chemotherapy in metastatic squamous non-small cell lung cancer patients
    Zheng, Hanrui
    Zeng, Ya
    Wen, Feng
    Hu, Ming
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden
    Criss, Steven D.
    Palazzo, Lauren
    Watson, Tina R.
    Paquette, Adelle M.
    Sigel, Keith
    Wisnivesky, Juan
    Kong, Chung Yin
    [J]. PLOS ONE, 2020, 15 (01):
  • [6] Cost-Effectiveness of Hybrid PET/CT for Staging of Non-Small Cell Lung Cancer
    Schreyoegg, Jonas
    Weller, Julia
    Stargardt, Tom
    Herrmann, Ken
    Bluemel, Christina
    Dechow, Tobias
    Glatting, Gerhard
    Krause, Bernd J.
    Mottaghy, Felix
    Reske, Sven N.
    Buck, Andreas K.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11): : 1668 - 1675
  • [7] Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer
    Czarnecka-Kujawa, Katarzyna
    Rochau, Ursula
    Siebert, Uwe
    Atenafu, Eshetu
    Darling, Gail
    Waddell, Thomas Kenneth
    Pierre, Andrew
    De Perrot, Marc
    Cypel, Marcelo
    Keshavjee, Shaf
    Yasufuku, Kazuhiro
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (06): : 1567 - 1576
  • [8] COST-EFFECTIVENESS OF MULTIPLEXED PREDICTIVE BIOMARKER SCREENING IN NON-SMALL CELL LUNG CANCER
    Romanus, D.
    Cardarella, S.
    Cutler, D.
    Landrum, M. B.
    Lindeman, N.
    Gazelle, G. S.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A204 - A204
  • [9] A REVIEW OF COST-EFFECTIVENESS STUDIES OF PEMBROLIZUMAB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Qiao, N.
    Insinga, R.
    Burke, T.
    Lopes, G.
    [J]. VALUE IN HEALTH, 2020, 23 : S41 - S42
  • [10] Comparing the cost-effectiveness of perioperative immunotherapy strategies in non-small cell lung cancer
    Muthusamy, B.
    Zabor, E. C.
    Pennell, N. A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S743 - S743
12345